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Cytochrome P450 (CYP) is a superfamily of enzymes in charge of elimination of the majority
of clinically used drugs and other xenobiotics. This study focuses on the development of a rapid
microfluidic lateral flow assay to study human phase I metabolism reactions mediated by
CYP2A6 isoenzyme, the major detoxification route for many known carcinogens and drugs,
with coumarin 7-hydroxylation, as the prototype model reaction. The lateral flow assay is
fabricated utilizing custom-designed porous functional calcium carbonate (FCC) based
substrates and inkjet-printed fluid barriers. All materials used are carefully characterized with
a view to preserve biocompatibility. The final assay comprises separate zones for reaction,
separation and detection, and an absorbent pad to keep the assay wet for extended periods (up
to 10 min) even when heated to physiological temperature. The overall concept allows one to
2
carry  out  CYP  assays  at  lower  cost  than  conventional  well-plate  assays,  while  providing
increased selectivity at equally high speed, owing to the possibility for simultaneous
chromatographic separation of the reaction products from the reactants on the FCC coating.
The developed concept thus provides a viable approach for rapid prediction of the interaction
risks related to metabolic clearance of drugs and other xenobiotics.
1. Introduction
Modern drug discovery provides an enormous number of new drug candidates, the properties
of which need to be carefully characterized as early as possible during the preclinical phase in
order to identify the most potential lead compounds for further optimization. The drug
discovery cycle from a lead compound to the commercial product is a capital-intensive process,
which would greatly benefit from more economic and efficient in vitro tools that are capable of
speeding up the preclinical screening. All new chemical entities (NCE) need to be screened for
their pharmacokinetic properties, including absorption, distribution, metabolism, excretion and
toxicology (ADMET), which forms a bottleneck in the drug discovery cycle. Although many
of these steps can be predicted by computer-aided design, the selectivity of enzymatic
biotransformation reactions cannot be reproduced reliably by any known non-enzymatic
technique[1] and, thus, the metabolic profile needs to be confirmed experimentally. Particularly
important is the prediction of the metabolic interactions mediated by the cytochrome P450
(CYP)  system,  which  is  a  superfamily  of  enzymes  accounting  for  about  75  % of  the  human
phase I  metabolism of all  clinically used drugs along with endogenous steroid synthesis and
detoxification of numerous other xenobiotics.[2] In addition to drug-drug interactions, it is
important to examine the risk of metabolic interactions between clinically used drugs and the
environmental chemicals for which humans are unintentionally exposed to on a daily basis.
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Many of such unintentionally uptaken chemicals are small molecules that occupy the CYP
system as their main detoxification route (first phase metabolism) same as drugs. [3]
Microfluidic paper-based lateral flow assays represent one of the most promising and fast-
growing new fields in bioanalytical chemistry, point-of-care (POC) medical diagnosis,
environmental analysis and food quality testing.[4] Paper-based assays offer small, simple-to-
use, low-cost, portable and disposable platforms exploiting capillary-driven liquid transport.[5]
Paper fluidic assays can be patterned using a range of techniques, including
photolithography,[5a,6] plasma[7] and laser treatment[8] or by using printing methods such as wax
printing,[9] screen printing,[6c,10] flexography[11] or inkjet.[12] Inkjet printing in particular enables
a simple and low-cost mass production of microfluidic devices. [13]
Filter and chromatography papers are the most widely used substrates in microfluidic paper-
based assays,[14] though such papers have the disadvantages of fibrous and heterogeneous
consistency and the coarse scale of their pore structure. In addition to filter and chromatography
papers, some researchers have used copy paper,[11b,15] but such paper has low wicking
capabilities making it, as such, unsuitable for flow assays.[15] Furthermore, commercial papers
may contain biocides that inhibit the enzyme activities or other additives that cause high optical
background (especially when exposed in the UV range) and, thus, render them unsuitable for
trace-level detection of pharmaceuticals and other small molecules.[4a,16] Until now, most paper-
based biosensors have been developed with a view to colorimetric detection of, for instance,
glucose and other abundant biomolecules[5,9a,11a,b,12a,b], or of tailor-made antigen-antibody
binding.[17] Paper-based assays capable of direct optical detection of the low concentrations of
pharmaceuticals and other alike small molecules could provide for beneficial development
opportunities.
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Custom-designed functional materials have recently been developed for use in coatings with a
view to microfluidic assays.[11b,18] The benefit of highly porous coating is its homogeneous
surface  with  a  finer  and  tailorable  pore  network  structure,  which  allows  not  only  the  use  of
lower sample volumes but also the fabrication of assays with higher feature resolution and more
uniform flow characteristics. In this study, a coated lateral flow CYP2A6 assay was fabricated
utilizing specially designed porous functionalized calcium carbonate (FCC) as the hydrophilic
wicking material, with microfluidic path control defined by inkjet-printed hydrophobic barriers.
The coating formulation was optimized to achieve enhanced porosity and elongated wetting
capabilities, the components having been carefully examined for their biocompatibility
regarding the desired end use as a disposable CYP lateral flow assay. The printing conditions
were also optimized to achieve either fully fluid impermeable, or controlled semi-impermeable,
barriers to prevent or allow selectively the passage of both eluent toward the reaction zone and
the reaction product-containing solution onward to the separation channel and eventually
entering the measurement endpoint region. The CYP enzymes were incorporated into the assay
in human liver microsomes (HLM) containing all of the main CYP isoforms, and coumarin 7-
hydroxylation was used as the prototypic model activity for CYP2A6 isoenzyme. CYP2A6 was
chosen as the primarily targeted isoenzyme, as it is an important detoxification route for many
carcinogens, such as nicotine,[19] and thus a likely target of drug-carcinogen interactions. The
performance of the final assay was validated in terms of the dependency between the amounts
of the formed metabolite, 7-hydroxycoumarin, and the applied enzyme, which lays the basis for
further use of the developed lateral flow assays in determining the enzyme inhibition kinetics
(e.g. the IC50 and Ki parameters).
2. Results and Discussion
2.1 Selection of materials
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Coating fabrication design for the lateral flow CYP assay was initiated by careful
characterization of the constituent materials for their compatibility with CYP enzymes using
conventional  in-solution  assays.  The  effects  of  FCC  and  two  different  binders,  i.e.
microfibrillated celluloses (MFC A and MFC B), on the chosen CYP2A6 model activity,
coumarin 7-hydroxylation, were determined by adding each compound separately to the
enzyme incubation solution and comparing the obtained enzyme activity to that of the control
incubation. No significant alterations in the enzyme activity were observed upon addition of
FCC, MFC A or MFC B, suggesting that the risk of mechanistic inhibition by the chosen coating
pigment or the binders is negligible (Figure 1a). The hydrophobizing agents used in printing
the fluidic barriers, polystyrene (PS) and alkyl ketene dimer (AKD), were both insoluble in
water. Thus, PS or AKD were not considered capable of diffusing into the point of CYP assay,
which was to be performed on otherwise non-printed FCC-based coating. In addition,
nonspecific adsorption of the CYP reaction components based on hydrophobic interaction was
also considered negligible. Therefore, the overall effect of the inks on the CYP activity could
be assumed negligible.
The effect of surface charge characteristics was studied using two commonly used
polyelectrolyte charge modifiers, cationic poly(diallyldimethylammonium chloride)
(polyDADMAC) and anionic sodium polyacrylate (NaPA), and their impact on CYP2A6 model
activity were determined by adding FCC modified with either compound to the enzyme
incubation solution. As a result, polyDADMAC was shown to reduce the enzyme activity by
half, whereas addition of NaPA resulted in about 40 % increase in enzyme activity compared
with the control (Figure 1a). On the basis of these results, it was concluded that the use of these
surface charge modifiers should be avoided altogether or prevented from coming into contact
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with the CYP enzyme due to uncertainty in the control of non-adsorbed polyelectrolyte
concentration.
In addition to enzyme compatibility, the optical background of the FCC coatings was compared
to that originating from a commercial filter paper (Whatman® Grade 1). On FCC, the lower
limits of detection (LOD) and quantitation (LOQ) were determined for 7-hydroxycoumarin
applied within printed containment ring patterns (inner diameter (i.d.) 5.0 mm, 2 mm wide
barrier,  volume  uptake  1.0  -  1.8 mL  depending  on  the  composition  (Table S1)) defined by
hydrophobic ink printed on the FCC coatings (Figure 1c). The calibration curves were
established by applying 7-hydroxycoumarin onto the containment area (or filter paper). Sodium
borate  (20 mM, pH 10.0) was used as the buffer to reach the maximum fluorescence quantum
yield of 7-hydroxycoumarin, which is strongly pH dependent.[20] Printing of similar ring
patterns on filter paper was not feasible due to uncontrolled spreading of the AKD ink inside
the ring patterns, rendering them completely hydrophobic. Therefore, the LOD and LOQ on
filter paper were determined by applying the analyte directly onto the paper. To facilitate
comparison of the LOD and LOQ levels between materials, the calibration curves were
established as a function of the mole amount of the applied substance. The FCC coatings gave
somewhat steeper slopes of calibration curve, indicating slightly better sensitivity compared
with that of the filter paper (Figure 1b). LOD/LOQ were determined according to ICH
guidelines[21] and were 0.5/1.4, 0.4/1.4 and 0.7/2.1 pmol for 7-hydroxycoumarin applied on
FCC with MFC A, FCC with MFC B and filter paper, respectively. The observed differences
are likely due to the lower UV background originating from the FCC coating (3.0 ± 0.5 a.u.,
FCC + 5 pph MFC B, sampling number n = 36) compared with that of the filter paper (6.6 ±
0.5 a.u., n = 36) (Figure 1b). On the basis of these results, it was concluded that FCC substrates
provide a sensitive platform for the lateral flow assays, which is particularly important when
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quantifying the trace-level amounts of drugs and their metabolites based on their inherent
fluorescence in the UV range.
2.2. Characterization of the wetting properties of the coating material
To enhance the liquid wicking elongation capacity, the FCC-based coating formulations were
optimized to maximize the pigment solids content and so to minimize the binder amount
(quoted as parts by weight in respect to 100 parts by weight of FCC (pph)). The more the binder,
the more porosity is reduced and, thus, the wetting and wicking capabilities of the coating are
affected adversely. However, there must be sufficient amount of binder to bind the FCC
particles to each other and to the base substrate to deliver a strong enough coated substrate
which endures handling and printing.
In this study, two binder loadings, 5 pph and 10 pph, for each binder (MFC A and B) were first
characterized in terms of their porosity profiles. Figure 2a  shows  the  first  derivative  of  the
cumulative mercury porosimetry intrusion curves of each of the four compositions. The data
are presented in terms of specific pore volume, i.e. the pore volume in a given size range per
unit  weight of the sample.  The main peaks in the pore size distribution between 1 – 3.1 µm
represent the interparticle pore volume, which contributes to permeability. The secondary peaks
below 1 µm represent the intraparticle pore size distributions, i.e. the internal pore volumes of
the FCC particles, which ensure high capillarity. Both of these factors facilitate fast absorption
of liquids within the coating.[22] Figure  2a  clearly  shows  that  MFC  A  at  10  pph  fills  the
interparticle pores less than MFC B. MFC B exhibited higher binding power due to its greater
degree of dispersed nanofibrilliated cellulose fines (Figure 2b and c). Since the amount of
binder also affects the volume of the interparticle pores of the coating (the more MFC is used,
the less permeable the coating), we chose to use MFC B at 5 pph concentration as the binder in
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this study to maintain the balance between maximizing the (sample) volume uptake and
permeation wicking capability of the final assays whilst maintaining sufficient strength (see
Table S2 for comparison of the interparticle specific pore volumes).
As illustrated in Figure 3, both volume uptake and evaporation rate can be altered by tuning
the coating composition. The total volume uptake capacity of aqueous samples was in the range
of 0.05 – 0.09 µL.mm-2 depending on the composition, with the highest volume uptake obtained
with FCC containing 5 pph of MFC B, as expected (Figure 3a). Almost a two-fold increase in
the volume uptake was reached adopting the MFC B at 5 pph versus MFC A at the strength-
demanding 10 pph. The differences observed between the theoretical and measured uptake
volumes (Figure 3a) are likely related to both the binder’s abilities to swell and absorb water,
which results in deviation between the nominal and wetted volume occupancy in the coating,
together with the observed spreading of AKD ink during print application, in turn reducing the
inner diameter of the containment rings. On average, the ring cells stayed wetted for
approximately 13 - 18 min at room temperature (Table S1). The evaporation rates were shown
to be somewhat similar between the two binders at the lower 5 pph concentration, whereas
increase in the binder amount seemed to slow down evaporation slightly,  more so in case of
MFC A than MFC B (Figure 3b).  This confirms that evaporation is not related to bulk flow
since the interparticle pore size, i.e. the permeability of the coating, is reduced (but not volume)
in the case of MFC B when the binder level is increased. However, if we consider the surface
area increase presented by the interparticle MFC matrix, seen as finer interparticle pores at the
same pore volume (Figure 2c and Table S2), and that evaporation is diffusion and film flow
driven rather than bulk flow driven, the reduction in bulk permeability is probably compensated
for by the evaporative surface area increase. The ability of the MFC in question to swell and
absorb water means that the binder itself, though solid in the porosimetry measurement,
contributes to experimental effective porosity when wetted.
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2.3 Optimization of the Assay Design
The final CYP assay was designed to comprise separate zones for enzyme reaction, separation
(of the reaction components) and detection (of the metabolite), and an absorbent pad applied to
the liquid feed reservoir to keep the assay wet for extended periods (up to 10 min), even when
heated to physiological temperature (Figure 4a). In addition to FCC, both binders, MFC A and
B, were equally compatible with the enzymes (Figure 1a) and provided somewhat similar
detection sensitivity in the UV range (Figure 1b). However, given the better wetting properties
and binding power at low binder dosage when using MFC B, as described previously, FCC with
MFC B (5 pph) was again chosen on these grounds as the coating formulation for further design
development.
Although the FCC substrates remained wet for several minutes at room temperature, it was
considered necessary, as mentioned above, to add a pre-wetted absorbent pad to the final assay
design to be placed in contact with the reservoir to ensure that the reaction zone stays wet during
the prolonged reaction times also at elevated temperature. Therefore, glass wool, pre-wetted
with the buffer (0.1M Tris,  pH 7.5) formed into an absorbent pad was incorporated together
providing a constant supply of fresh buffer from the reservoir to the reaction zone.  The duration
of the enzyme incubation (reaction) period was adjusted to ensure that a sufficiently high
amount of metabolite(s) is formed to exceed the LOQ of 7-hydroxycoumarin (ca. 1.4 pmol,
Figure 1b).
After enzyme reaction, the assay was allowed to dry for 30 min prior to elution of the reaction
components to the separation zone and eventually, the detection spot. The substrate of the
chosen model reaction, coumarin 7-hydroxylation via CYP2A6, is non-fluorescent over the
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entire pH range and so does not interfere with the detection of the fluorescent metabolite (7-
hydroxycoumarin). However, the cosubstrate (NADPH) has faint fluorescence in the near-UV
range, which overlaps with the metabolite’s fluorescence spectrum at neutral and basic pH.
Since NADPH is typically added to the CYP reaction solutions in excess, its concentration is
easily ca. 100-fold greater than that of the formed metabolite, and thus NADPH complicates
the fluorescence detection of the metabolite. In conventional CYP2A6 well-plate assays this
can be overcome by acidifying the reaction solution prior to detection, typically with perchloric
acid, which simultaneously denatures the enzyme and so terminates the reaction, after which
the fluorescence excitation and emission maxima of NADPH and 7-hydroxycoumarin appear
at different spectral wavelengths.[20] However, acidification is not possible on the FCC-based
lateral flow assay, because the acid would react with the carbonate fraction in FCC. Therefore,
in-line separation from NADPH is required prior to detection of the metabolite. Conveniently,
the coating material itself enables chromatographic separation of the chosen reaction
components following the enzymatic reaction, as illustrated in Figure 4b. Chromatographic
separation of the reaction components is also crucial in case the substrate and metabolite (of
other CYP model reactions, for example) cannot be selectively separated based on their
fluorescence properties alone, similarly to non-fluorescent coumarin and its fluorescent
metabolite, 7-hydroxycoumarin.
To facilitate online chromatographic separation upon elution of the reaction solution from the
reaction zone to the detection spot, a 3-mm-wide and 15-mm-long separation channel was
patterned into the final design. The assay and channel dimensions were outlined by full barriers
using two inkjet applied AKD ink layers (96.5 ± 7.0 cm3m-2).[12f] The channel is separated from
the reaction zone by a semi-barrier (Figure 4a). The semi-barrier retains the reaction solution
in the designated zone while the reaction is running, liquid being fed by the absorbent pad used
as the fresh buffer storage, but afterwards allows elution of the reaction components upon
11
application of the elution buffer (20 mM sodium borate, pH 10). The semi-permeable fluid
barrier between the reaction and separation zones was inkjet printed using polystyrene (PS) ink,
which is known to require many more application layers to become fully water-tight, and thus
provides for precise control of permeability according to the number of layers applied.[12f] Four
layers of PS ink was found to work satisfactorily to prevent liquid from spreading into the
separation channel during the reaction with the absorbent moistening pad in place, whilst
allowing the liquid to flow through upon application of the elution buffer.
With the final assay design (Figure 4a), 25 µL of the elution buffer was required to induce high
enough wicking force to overcome the repulsion forces of the semi-barrier and to ensure full
wetting of the separation zone until the arrow-shaped detection spot. The length of the
separation channel determines the total wetted area, and, thus, the required buffer volume,
which eventually affects the elution time. Based on the material specific volume uptake data
(Figure 2a), the theoretical volume required to wet the final assay (here, 142 mm2) was 13 mL,
which is in line with the experimentally determined elution volume (25 mL), taking the
evaporation into consideration. If needed, larger elution volumes can also be used for wetting
an even longer separation path (larger areas), thus increasing the overall chromatographic
resolving power. In this work, however, a relatively short separation path was favored because
it allowed for shorter elution times (ca. 5 min) and the chromatographic separation of the
metabolite from NADPH was obtained easily, as described below. It was also shown that the
capillary wicking kinetics of the final assay design were well repeatable (Figure 4c), including
the slow down effect by the semi-barrier.
To characterize the chromatographic behavior of the coating formulation, thin layer
chromatography (TLC) experiments were performed independently to optimize the conditions
for separation of NADPH and 7-hydroxycoumarin. For this purpose, glass slides were coated
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with FCC containing 5 pph MFC B and NADPH (1 nmol) and 7-hydroxycoumarin (0.5 nmol)
were applied to the FCC substrate in the incubation buffer (0.1M Tris, pH 7.5) and eluted with
the elution buffer (20 mM sodium borate, pH 10) (Figure S1).  It  was  observed  that  7-
hydroxycoumarin eluted along with the solvent front with an Rf value of ca. 1, whereas the
anionic NADPH was significantly retained by the FCC (Figure 4d). The surface of FCC consists
of pores built from protruding hydroxyapatite platelet structures on a calcium carbonate
particulate core, and, thus, while the particle pores are anionic, the edges of the platelets have
a slight cationic charge[23] capable of interacting with the anionic NADPH. To investigate
further the impact of surface charge compared with the inherent zwitterionic nature of FCC,
either anionic (sodium polyacrylate, NaPA) or cationic (polyDADMAC) polyelectrolyte
solution was applied on FCC by inkjet printing to neutralize the inherent complementary
charge.[24] As expected, the chromatographic behavior of NADPH and 7-hydroxycoumarin
when applied onto the cationic treatment was similar to that on bare FCC (Figure 4d). When
the compounds were applied on the anionically treated surface, NADPH was no longer retained
based on strong electrostatic interaction, but only by weak hydrophilic interaction, and thus
eluted  closer  to  the  solvent  front  with Rf of ca. 0.75 (Figure 4d). The possibility to tune the
inherent surface chemistry of FCC locally via inkjet printing of cationic or anionic treatments
further increases the selectivity of separation, although care should be taken, as mentioned
earlier, not to include the treatments at the point of enzymatic reaction due to their potential
inhibitory or enhancing effects on the enzyme activity (Figure 1a). In this work, bare FCC was
found sufficient to provide chromatographic separation of the reaction components, and so
charge addition was not further pursued. On the final design, the obtained Rf values for NADPH
and 7-hydroxycoumarin were 0.23 ± 0.01 and 0.98 ± 0.03, respectively. When in excess
compared with the FCC cationic adsorption capacity, NADPH is not fully adsorbed at the
reaction zone, maintaining its reactivity, but will be retained by the coating during wicking in
the separation channel even if penetrating the semi-barrier.
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Finally,  the  geometry  of  the  detection  spot  was  also  optimized.  Instead  of  using  the  round-
shaped end (similar to ring patterns), an arrowhead shape was adopted to the final design. This
was to avoid the Marangoni effect (coffee stain ring), which is characteristic to ring patterns
and results in concentration of the analytes around the edges. Instead, the arrowhead shape
enables concentration of the sample into a well-defined area at the tip. However, depending on
the detection window size and shape, the detected area may also partly cover the AKD ink
barrier, which may induce significant background due to its autofluorescence. In this work, by
carefully selecting the dye used for visualizing the hydrophobic barriers, we were able to
eliminate the AKD-related background as the blue dyed layer formed on and between the
coating pigment particles effectively scattered the UV light (at the excitation wavelengths used,
355  ±  5  nm),  with  no  emission  at  the  desired  emission  wavelength  range  (in  the  detected
emission  wavelength  range  of  400  -  700  nm).  Some  portions  of  the  fluorescence  readings
nonetheless may originate from the AKD ink, because the AKD spreads more than the dye on
the coating. Therefore, fluorescence was recorded before and after elution for all arrowhead
tips, and the background (before) was subtracted from the final values (after) case-by-case.
2.4 Validation of the lateral flow CYP2A6 assays
Once the microfluidic design was optimized, the detection sensitivity of the final assay was
determined according to ICH guidelines.[21] Before fluorescence detection, the desired amounts
of metabolite were applied onto the reaction zones in 1.5 µL volumes of 0.1 M Tris buffer (pH
7.5),  allowed to  dry,  and  eluted  to  the  end  of  the  separation  channel  with  25  µL of  20  mM
sodium borate buffer (pH 10). To account for all possible background interference originating
from the reaction components, both NADPH (1.5 nmol) and HLM (1.5 µg) were also applied
on each assay prior to addition of 7-hydroxycoumarin. In addition, the assay was heated to 37
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ºC before elution to include the effects of possible heat degradation products (of NADPH, for
example). Under these conditions, the obtained LOD and LOQ were 0.9 and 2.7 pmol,
respectively, which were very well in line with those obtained with the ring patterns (Figure
1b), indicating that no significant loss of sample takes place during the elution (separation) step.
The linearity of the assay was also sufficiently good (R2 = 0.9554) between 0.38 and 3.00 pmol
(Figure 5a).
Finally, CYP2A6 enzyme reactions were carried out on the developed lateral flow assays to
examine their feasibility for preclinical in vitro drug-drug or drug-chemical interaction
screening. In conventional end-point assays, the reaction is typically initiated by the addition
of  the  cosubstrate  and  terminated  by  the  addition  of  the  acid  or  organic  solvent,  which
precipitates the proteins. In this work, the reaction was terminated by removing the absorbent
pad at  a fixed time point (t = 10 min),  which resulted in denaturation of the proteins due to
drying. The lateral flow enzyme reactions were carried out by applying the cosubstrate
(NADPH, 1.5 nmol in deionized (DI) water) and the substrate (coumarin, 75 pmol in DI water)
onto the reaction zone, allowing drying between applications, after which the pre-wetted
absorbent pad was placed over the reservoir and HLM (1.5 - 15 µg in 0.1 M Tris buffer, pH
7.5) was applied to the reaction zone to initiate the reaction. The assay was heated to 37 ºC prior
to addition of any further reagents, and kept wet for 10 min by adding more buffer to the
absorbent pad, if needed. After the 10 min reaction period, the absorbent pad was removed and
the assay allowed to dry. The reaction products were then eluted to the separation channel with
25  µL  of  the  20  mM  sodium  borate  (pH  10.0)  buffer,  as  described  earlier,  so  as  to  allow
simultaneous pH shift from the neutral reaction pH of 7.5 to basic detection pH of 10.0
(providing maximum quantum yield for umbelliferone at ex 355 nm).
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To be able to determine the critical enzyme inhibition parameters from observed interactions,
i.e., at half maximum inhibition IC50 or inhibitory constant Ki, it is important to ensure that the
reaction kinetics is linearly dependent on the enzyme amount and the reaction time. Here, the
metabolite production rate (pmol.min-1) increased linearly as a function of enzyme
concentration between 1.5 and 15 µg total protein concentration (HLM) (R2 = 0.9520) (Figure
5b). At the lowest total protein concentrations, however, the amount of metabolite formed was
so small that the inherent deviation in the biological enzyme activity, combined with the
precision of the reagent dosing, overpowered the metabolite signal and resulted in relatively
large variation between the parallel assays (n = 4 at each total protein concentration level, Figure
5b). However, a statistically significant difference (p = 0.032) to the negative control reactions
without the enzyme (44 ± 15 fmol.min-1, n = 4) was obtained until at total protein concentration
of 12 mg (134 ± 53 fmol.min-1, n = 4). This concentration was still in the linear range suggesting
feasibility of the assay for the envisioned enzyme inhibition screening. In all, these results
suggest that the developed lateral flow CYP assay might serve as a rapid and low-cost
interaction screening assay.
3. Conclusions
A microfluidic lateral flow assay to study human phase I metabolism interactions mediated by
cytochrome P450 (CYP) enzymes was developed. The lateral flow assay is constructed from a
specialty porous particle coating (FCC) and MFC binder. An inkjet-printed hydrophobic barrier
pattern, including both fully and semi-impermeable components, is fabricated on the coating
using AKD and PS inks, respectively. The assay consists of three zones, each for the enzymatic
reaction, the separation of the reaction products and the detection of the formed metabolite.
These are supplemented by a buffer reservoir zone and an absorbent pad to facilitate constant
wetting of the substrate for prolonged reaction times even at elevated temperatures (here, 37
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∞C). The design also compises a semi-barrier to prevent the reaction solution from escaping to
the separation zone during the enzymatic reaction. The properties of the coating enable
chromatographic separation of the reaction components and, thus, selective transport of the
metabolite to the detection zone, where the metabolite can be quantified based on UV
fluorescence. Conveniently, sensitive detection of the chosen model compounds is facilitated
by the fact that the coating material in itself shows no significant background intereference
(autofluorescence).
To our knowledge, the concept of microfluidic, inkjet-printed lateral flow assays has not been
applied to CYP metabolism research until the present work. Our proof-of-concept assays show
that the FCC-based platform coupled with fluorescence detection is a simple and viable method
for studying CYP2A6 mediated reactions in vitro, and, thus, provides a convenient screening
tool to examine the drug-drug or drug-chemical interactions at comparatively low cost
compared with the conventional well-plate assays. The reduced consumption of biochemicals
and lower amount of waste not only decrease the total costs, but have added value as such
toward sustainable development making use of sustainable raw materials. In addition to lower
cost, the possibility for sample manipulation (e.g., separation of reaction components) via
chromatographic interaction - enforced by selective surface modifications, if needed – provides
a clear advantage over conventional well-plate assays.
4. Experimental Section
Coating Preparation: A highly porous form of pharmaceutical grade FCC, provided by Omya
International AG, Oftringen, Switzerland, in which the functionalization consists of a shell-core
structure of hydroxyapatite (52.7 %) and calcium carbonate (47.3 %), was used as a coating
pigment.  Two types  of  MFC,  a  commercially  available  Arbocel  MF-40-7  (J.  Rettenmaier  &
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Söhne GmbH + Co KG, Rosenberg, Germany), termed MFC A, and a mechanically produced
micro nanofibrillated cellulose (Omya International AG, Oftringen, Switzerland), termed MFC
B, were evaluated as binders. SuperYUPO® (Yupo Corporation, Tokyo, Japan), pigment filled
polypropylene  film (thickness  80  µm),  was  used  as  the  inert  base  substrate  for  the  coatings.
Coating colors were applied with a K202 Control Coater (RK PrintCoat Instruments Ltd.,
Litlington, UK.) employing two spirally wound rods, applying a 150 µm (MFC A containing)
and a 400 µm (MFC B containing) thick coating, respectively, as a wet layer with a speed
setting of 6 m·min-1. The coatings were dried in laboratory atmosphere.
Coating Characterization: Solids  content  was  determined  with  a  Precisa  HA  300  Moisture
Balance (Precisa Gravimetrics AG, Dietikon, Switzerland). Viscosity was measured using a
Brookfield DV-II+ viscometer (Brookfield Engineering Laboratories, Inc., Massachusetts,
USA) using spindle #4 and a rotation speed of 100 min−1. Coat weight was calculated by
measuring the weight of pieces of the coated polypropylene film (5 x 5 cm2), using a Mettler
AE260 analytical balance (Mettler-Toledo International Inc., Columbus, Ohio, USA),
deducting  the  weight  of  the  film  and  dividing  with  the  area  of  the  sample  (n =  5).  Coating
thickness was measured with an SE250D micrometer (Lorentzen & Wettre, Kista, Sweden),
having a 2 cm2 measurement area spindle and measurement pressure of 100 kPa (n = 10). The
dry coating thickness was determined from the measured coated films by subtracting the
nominal thickness of the polypropylene film. Scanning electron micrographs (SEM) were
obtained with a Sigma VP field emission scanning electron microscope (Carl Zeiss AG,
Oberkochen, Germany). Coating pore volume was measured with an Autopore IV mercury
intrusion porosimeter (Micromeritics, Norcross, USA) from coating samples dried in a petri
dish (diameter 5.5 cm) in normal laboratory conditions. Table S3 shows the properties of the
coating formulations. The measured uptake volumes were experimentally determined by
applying different volumes of Tris buffer into the center of the ring cell (i.d. = 5 mm) until a
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reflective liquid layer remaining on the surface was just apparent. The theoretical total volume
uptake was calculated by multiplying the internal area of the circular ring cell, the coat weight
of the given coating and the corresponding specific pore volume data (Table S1). Evaporation
experiments were performed by applying Tris buffer (1.0 – 1.8 µL; 0.1 M, pH 7.5) with MgCl2
(3.5 mM) onto the central area of inkjet-printed rings (or on filter paper) and measuring the
change of mass as a function of time with a Mettler Toledo MT5 microbalance coupled with
Mettler Toledo Balance Link – DSC software (Mettler-Toledo International Inc., Columbus,
Ohio, USA) (n = 3).
Functional Ink and Printing of Patterns: Two  functional  inks,  using  two  different
hydrophobizing agents, were used to fabricate patterns onto the coated samples.[11e,f] The inks
were formulated using polystyrene PS (Sigma-Aldrich, St. Louis, USA) and alkyl ketene dimer
AKD (BASF, Ludwigshafen, Germany), dissolved in p-xylene solvent (VWR, Vienna, Austria).
The PS ink was colored with Sudan Red G (Sigma-Aldrich, St. Louis, USA), and the AKD ink
was colored with Blue 807 dye (Kremer Pigmente GmbH, & Co. KG, Aichstetten, Germany)
as markers. Both inks were printed using 10 µm drop spacing using a DMP-2831 research inkjet
printer (Fujifilm Dimatix, Santa Clara, USA) employing DMC-11610 ink cartridges with 10
pL nominal drop volume. Two polyelectrolyte-based inks, cationic (polyDADMAC) and
anionic (sodium polyacrylate NaPA) were used to modify the surface charge of the coating. [22]
The polyDADMAC ink was printed using 15 µm drop spacing (6 layers) and NaPa ink using
12 µm drop spacing (6 layers).
Reagents used in Lateral Flow Enzyme Assays: Human liver microsomes (HLM) were
purchased from BD Biosciences (Woburn, MA, USA). Coumarin, 7-hydroxycoumarin
(umbelliferone), β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt
hydrate (NADPH), dimethyl sulfoxide (DMSO) and Trizma base were purchased from Sigma-
19
Aldrich  (St.  Louis,  MO,  USA).  Magnesium chloride  (MgCl2), boric acid, hydrochloric acid,
and perchloric acid (HClO4) were from Riedel-de-Haën (Seelze, Germany). All reagents and
solvents were of analytical or HPLC grade. Water was purified with a Milli-Q water purification
system (Millipore, Molsheim, France).
Characterization of the materials-enzyme compatibility: FCC, the binders MFC A and B, and
the polyelectrolytes NaPA and polyDADMAC were individually screened for their potential
effect on the selected model reaction, i.e. CYP2A6-mediated coumarin 7-hydroxylation. These
reactions were carried out in a total volume of 100 mL of Tris buffer (0.1 M, 3.5 mM MgCl2,
pH  7.5)  in  the  presence  of  HLM  (0.4  mg.mL-1),  NADPH  (1  mM)  and  coumarin  (4  µM).
Respectively, FCC (20 w/w%), MFC A (6.32 w/w%) and MFC B (1.32 w/w%) was added to
the reaction mixture as aqueous suspension prior to dilution to the final reaction volume. The
NaPA and polyDADMAC were added to the reaction mixture together with the FCC using 0.5
pph  concentration,  each  with  respect  to  solid  content  of  26  w/w%  and  24  w/w%  FCC,
respectively. The enzyme reactions were carried out in Eppendorf tubes and initiated by the
addition  of  NADPH,  incubated  for  15  min  at  37  °C  and  terminated  with  the  addition  of
perchloric acid (10 µL, 4 M). The reaction solutions were put on ice for about 10 min to allow
the proteins to precipitate, after which they were centrifuged for 10 min at 16 000 g. The
supernatants were then separated for analysis on a Varioskan® Flash well-plate reader (Thermo
Scientific, Vantaa, Finland). The amount of 7-hydroxycoumarin was quantified using
fluorescence detection (excitation 325 nm, emission 470 nm) and the CYP2A6 activities were
compared between control reactions (no added materials) and reactions carried out in the
presence of FCC, MFC A, MFC B, NaPA or polyDADMAC.
Fluorescence Microscopy (Lateral Flow Assays): Fluorescence detection was accomplished
with a Zeiss Axioscope A1 upright epifluorescence microscope (Carl Zeiss Oy, Espoo, Finland)
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equipped with a 10¥ objective and a broad-band halogen lamp (HAL100W) with a 355 ± 10
nm filter as excitation source. The fluorescence emission was collected over the range 400 –
700 nm using a Hamamatsu R5929 photomultiplier tube equipped with integrated housing and
a signal amplifier module (Cairn Research). Coated platforms and a qualitative filter paper
(Whatman® Grade 1) purchased from Sigma-Aldrich (St. Louis, MO, USA) were used as
substrates.
Thin Layer Chromatography (TLC): The chromatographic separation of the co-substrate,
NADPH, and the metabolite, 7-hydroxycoumarin, on the FCC coating was investigated using
both  coated  microscope  glass  slides  (25  x  75  mm2,  VWR  International)  and  the  final  assay
design (FCC + 5 pph MFC B). In the case of coated glass slides, NADPH (1 µL, 1 mM) and
umbelliferone (1 µL, 500 µM) were pipetted onto the plain FCC + 5 pph MFC B coating and
onto inkjet-printed polyDADMAC or NaPA areas (1 x 2.5 cm2) on the coating (Figure S1), and
the samples were placed into a chromatographic chamber containing sodium borate buffer (20
mM, pH 10). The samples were examined under UV light using a MiniMatcher MM-4e (GTI
Graphic Technology Inc., New York, USA) equipped with a UV lamp (Philips TL 8W/08 F8
T5/BLB 365 nm) before and after the experiment. Chromatographic separation on the final
assay  design  (FCC  +  5  pph  MFC  B)  was  tested  by  pipetting  NADPH  (1.5  µL,  1  mM)  and
umbelliferone  (1.5  µL,  5  µM)  to  the  reaction  zone  and  eluting  the  sample  with  the  sodium
borate buffer solution (25 µL) in a horizontal orientation. The sample was examined under UV
light before and after elution. The retention factors (Rf) were calculated by dividing the distance
travelled by the compound of interest with the distance travelled by the solvent front.
Lateral flow enzyme assays: The background intensity of the sample was measured by pre-
wetting the tip of the arrowhead detection zone with the sodium borate buffer (0.5 µL).  The
sample was placed on a digital hot plate (model 062, Labotect) at 37 °C and allowed to warm
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up. NADPH (1 mM) and coumarin (50 µM) in DI water (1.5 µL) was pipetted to the reaction
zone and allowed to dry. Absorbent pad (Whatman® glass microfiber filter, Grade GF/F, GE
Healthcare Europe GmbH, Finland) pre-wetted with Tris buffer (25 µL, 0.1 M, pH 7.5)
containing MgCl2 (3.5 mM) was applied to the absorbent pad zone to keep the reaction zone
wetted. HLM in the Tris buffer (1.5 µL, 0-1-2-4-6-8-10 mg.mL-1 total protein concentration)
was applied to the reaction zone and more Tris buffer was dispensed to the absorbent pad, as
needed, during the 10 min experiment to ensure that the reaction zone stayed wet over the entire
reaction period. Negative controls were performed without HLM and without NADPH and
coumarin.  After 10 min the absorbent pad was removed and the sample was allowed to dry.
The metabolite was eluted to the detection zone by adding sodium borate buffer (20 mM, pH
10, 25 µL) to the moistening zone. The sample was then allowed to dry for at  least  30 min.
Fluorescence detection was carried out by re-wetting the tip with the sodium borate buffer (4
µL).
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Supporting Information is available from the Wiley Online Library or from the author.
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Figure 1. a) The influence of the coating pigment (FCC), the binders (MFC A and MFC B) and
the charge modifiers (NaPA and polyDADMAC) on the CYP2A6 activity. b) Comparison of
the calibration curves determined for 7-hydroxycoumarin using the two different FCC-based
coatings or the commercial filter paper. The error bars represent deviation between repeated
measurements (n = 3). c) Inkjet-printed ring patterns used in determination of the optical
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Figure 2. a)  Pore  size  distribution  of  the  different  coating  formulations  tested,  showing  the
significant reduction in interparticle specific pore volume, which controls permeability, on
increasing addition of binder (note: MFC B also reduces the interparticle pore size), and
scanning electron microscope (SEM) images of FCC particles combined with b) MFC A (10
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Figure 3. a) Comparison of the theoretical and measured volume uptake of the different coating
compositions tested. b) Comparison of the evaporation rate of the different coating
compositions tested – the error bars represent deviation between repeated measurements (n =
3) – to illustrate the enhanced evaporation rate obtained on the assay, a lower evaporation rate
of 0.04 ± 0.00 µL.min-1 was obtained for 1 µL of the aqueous buffer (0.1 M Tris, pH 7.5) applied
on an uncoated glass substrate.
Figure 4.  a) Photograph of the final assay design illustrating the different operation zones
implemented on the FCC substrates by inkjet printing and detected area marked with a red ring.
b) Photograph of the assay under UV lamp after an elution experiment illustrating the separation
of the highly fluorescent cosubstrate (NADPH) and the faint fluorescent metabolite (7-
hydroxycoumarin). c) The capillary wicking distance as a function of square root of time on the
final assay (n = 10 individual assays). The dash lines indicate the borders of the different zones
on the final assay (semi-barrier marked with a black dash line): (I) liquid reservoir, (II) reaction
zone, (III) separation zone, and (IV) detection spot. d) The retention factors (Rf) of 7-
hydroxycoumarin and NADPH when applied on top of non-treated FCC containing 5 pph MFC
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Figure 5. a)  Calibration  curve  of   the  final  assay,  b)  enzyme activity  and  c)  a  schematic  of
coumarin 7-hydroxylation taking place on a lateral flow assay.
















































Human phase I metabolism interactions mediated by cytochrome P450 can be studied
using a microfluidic lateral flow assay constructed from functionalized calcium carbonate
(FCC) and microfibrillated cellulose (MFC). The FCC-based platform coupled with
fluorescence detection offers a viable method for studying CYP enzyme interactions in vitro,
at comparatively low cost but with significantly increased selectivity compared to
conventional well-plate assays.
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